Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

Fig. 2

OS, PFS, DFS curves. a Progression-free survival of 11 adult LCH patients treated with the MACOP-B regimen in a 20-year period. b Disease-free survival of 8 adult LCH patients who obtained a CR after MACOP-B regimen. c Overall survival of 11 adult LCH patients treated with the MACOP-B regimen in a 20-year period. d Progression-free survival of 6 SS-m LCH and 5 MS LCH patients treated with the MACOP-B regimen in a 20-year period

Back to article page
\